行情中心 沪深京A股 上证指数 板块行情 股市异动 专题 涨跌情报站 盯盘 港股 研究所 直播 股票开户 智能选股
全球指数
数据中心 资金流向 融资融券 沪深港通 比价数据 研报数据 公告掘金 新股申购 大宗交易 业绩速递

贝泰妮:2026年半年度报告摘要_英文版

深圳证券交易所 08-25 00:00 查看全文

贝泰妮 --%

Yunnan Botanee Bio-Technology Group Co. Ltd. Summary of the 2026 Semi-annual Report

Stock code: 300957 Stock abbreviation: Botanee Announcement number: 2026-

047

Yunnan Botanee Bio-Technology Group Co. Ltd.Summary of the 2026 Semi-annual Report

I. Important Notice

(1) This semi-annual report summary is derived from the full text of the semi-annual report. To fully understand the Company’s

operating results financial status and future development plans investors should carefully read the full semi-annual report on the

media designated by the China Securities Regulatory Commission.

(2) All directors attended the Board meeting for deliberating on this report.

(3) Notice of the non-standard audit opinion

□ Applicable□ Not applicable

(4) Profit distribution plan or capital reserve transfer plan to increase capital approved by the Board during the reporting period

□Applicable Not applicable

The profit distribution plan approved by the Board during this meeting is: Based on the Company’s total share capital of

423600000 shares subtracting 6006818 shares in the repurchase special account that do not participate in the profit distribution

i.e. using 417593182 shares as the base a cash dividend of CNY1.50 (tax included) will be distributed for every 10 shares to all

shareholders with 0 bonus share (tax included) and 0 share for every 10 shares transferred to all shareholders from capital reserve.Whether capital reserves were transferred to increase capital

□ Yes□ No

(5) The profit distribution plan for preferred shares approved by the Board during the reporting period

□ Applicable□ Not applicable

II. Company Overview

1. Company Profile

Stock name Botanee Stock code 300957

1Yunnan Botanee Bio-Technology Group Co. Ltd. Summary of the 2026 Semi-annual Report

Stock listing exchange Shenzhen Stock Exchange

Contact person and contact information Board Secretary Securities representative

Name Wang Long Xu Minjing

Tel. 021-6232 1125 021-6232 1125

No. 53 Keyi Road Kunming High-tech No. 53 Keyi Road Kunming High-tech

Industrial Development Zone Kunming Industrial Development Zone Kunming

Office address

Yunnan Province Yunnan Province

Email ir@botanee.com ir@botanee.com

2. Key Accounting Data and Financial Indicators

Whether the Company retrospectively adjusted or restated accounting data for previous year

□ Yes□ No

Unit: CNY

YoY

increase/decrease

Same period of the

The reporting period compared with the

previous year

same period of the

previous year

Operating revenue 2591640131.46 2371842584.76 9.27%

Net profit attributable to our shareholders 291796816.97 246660804.39 18.30%

Net profit attributable to our shareholders after

246252636.86182617089.4934.85%

deducting non-recurring gains and losses

Net cash flow from operating activities 393862777.70 346928759.67 13.53%

Basic earnings per share (CNY/share) 0.69 0.58 18.97%

Diluted earnings per share (CNY/share) 0.69 0.58 18.97%

Increased by

Weighted average return on net assets 4.69% 4.02% approximately 0.67

percentage points

YoY

increase/decrease

End of the reporting End of the previous

compared with the

period year

end of the previous

year

Total assets 8192772445.34 8341346880.58 -1.78%

Net assets attributable to our shareholders 6154295456.26 6157265024.87 -0.05%

3. Total Number of Shareholders and Their Shareholdings

Unit: Share

Total number of

preferred

Ordinary

shareholders with Shareholders holding

shareholders as

36264 restored voting special voting shares

of the end of the

rights at the end of (if any)

reporting period

the reporting

period (if any)

2Yunnan Botanee Bio-Technology Group Co. Ltd. Summary of the 2026 Semi-annual Report

Shareholding of the top 10 shareholders (excluding shares loaned through refinancing)

Number of Pledged marked or frozen

Shareholdi Number of shares subject shares

Shareholder name Shareholder type

ng ratio shares held to trading Status of

restriction Quantityshares

Domestic non-

Kunming Nuona Technology

Co. Ltd. state-owned 45.97% 194743411 N/A

corporation

Tianjin Sequoia Juye Equity Domestic non-

Investment Partnership state-owned 4.83% 20476600 N/A

(Limited Partnership) corporation

Domestic non-

Yunnan Haqisheng Enterprise

Management Co. Ltd. state-owned 2.60% 10993678 N/A

corporation

Hong Kong Securities Overseas legal

Clearing Company Limited 2.17% 9211085 N/Aperson

Kuwait Investment Authority Overseas legal 1.26% 5333058 N/A

person

National Social Security Fund

Portfolio 118 Miscellaneous 1.00% 4223864 N/A

Goldman Sachs

International—Proprietary Overseas legal 0.96% 4069823 N/A

Funds person

Domestic non-

Xiamen Zhenli Consulting

Co. Ltd. state-owned 0.75% 3174921 N/A

corporation

Industrial and Commercial

Bank of China Limited — CSI

Main Consumer Exchange- Miscellaneous 0.68% 2894595 N/A

Traded Open-End Index

Securities Investment Fund

Zeng Xiangang Domestic natural 0.44% 1850000 N/A

person

Both Kunming Nuona Technology Co. Ltd. and Yunnan Haqisheng

Enterprise Management Co. Ltd. are enterprises controlled by the

Explanations of relationships between or concerted

Company’s actual controller Guo Zhenyu. Besides no connected

actions of the aforementioned shareholders

relationship and action in concert between the top 10 shareholders is

known to the Company.Zeng Xiangang holds no shares in the Company through an ordinary

Top 10 shareholders of ordinary shares

securities account and 1850000 shares through the customer margin

participating in securities margin trading business

trading guarantee securities account of China Securities Co. Ltd.(if any)

representing a total holding of 1850000 shares in the Company.

(1) The situation of shareholders holding more than 5% of shares the top 10 shareholders and the top 10 shareholders of

unrestricted tradable shares participating in shares loan through refinancing

□ Applicable□ Not applicable

(2) Changes occurred in the top 10 shareholders and the top 10 shareholders of unrestricted tradable shares compared with the

previous period due to shares loan through refinancing/return

□ Applicable□ Not applicable

(3) Whether the Company has differential voting rights arrangements

□ Yes□ No

3Yunnan Botanee Bio-Technology Group Co. Ltd. Summary of the 2026 Semi-annual Report

4. Changes in the Controlling Shareholder or Actual Controller

(1) Change in the controlling shareholder during the reporting period

□ Applicable□ Not applicable

(2) Change in the actual controller during the reporting period

□ Applicable□ Not applicable

5. Total Number of Preferred Shareholders and Shareholding of the Top 10 Preferred Shareholders

□ Applicable□ Not applicable

6. Bonds in Effect as of the Date of Approval of the Semi-annual Report

□ Applicable□ Not applicable

III. Significant Matters

For details please refer to the 2026 Semi-annual Report of Yunnan Botanee Bio-Technology Group Co. Ltd. (2026-046)

disclosed on CNINFO (http://www.cninfo.com.cn).

4

免责声明:用户发布的内容仅代表其个人观点,与九方智投无关,不作为投资建议,据此操作风险自担。请勿相信任何免费荐股、代客理财等内容,请勿添加发布内容用户的任何联系方式,谨防上当受骗。

相关股票

相关板块

  • 板块名称
  • 最新价
  • 涨跌幅

相关资讯

扫码下载

九方智投app

扫码关注

九方智投公众号

头条热搜

涨幅排行榜

  • 上证A股
  • 深证A股
  • 科创板
  • 排名
  • 股票名称
  • 最新价
  • 涨跌幅
  • 股圈